Biophenyx

biophenyx is the first company in the world that accurately and experimentally determines how genetic sequence variants/mutations (“what is coded?”) impact cell phenotypes (“what happens?”) biophenyx can do this on a small or grand scale, across all major organisms, all genes, and all small mutations – including mutations that cause disease – or are otherwise difficult to assess accurately. biophenyx uses this capability to provide service offerings to leading corporations in the pharma/biotech, in vitro diagnostics and life science industries, as well as for groundbreaking internal r&d activities.